Massachusetts Financial Services CO Regeneron Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 514,265 shares of REGN stock, worth $366 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

514,265

Previous 540,293 4.82%

Holding current value

$366 Million

Previous $568 Million 4.8%

% of portfolio

0.17%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $26.7 Million - $31.3 Million	-26,028 Reduced 4.82%	514,265 $541 Million
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $52.8 Million - $64 Million	59,769 Added 12.44%	540,293 $568 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $215 Million - $237 Million	238,174 Added 98.28%	480,524 $462 Million
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $5.33 Million - $6.07 Million	6,879 Added 2.92%	242,350 $213 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $218 Million - $266 Million	-315,252 Reduced 57.24%	235,471 $194 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $562,124 - $666,771	-803 Reduced 0.15%	550,723 $396 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $2.22 Million - $2.69 Million	3,257 Added 0.59%	551,526 $453 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $247 Million - $268 Million	349,860 Added 176.33%	548,269 $396 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $114 Million - $144 Million	198,409 New	198,409 $137 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $1.52 Million - $1.8 Million	-2,650 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $3.81 Million - $4.51 Million	-8,068 Reduced 75.28%	2,650 $1.48 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $48,693 - $59,753	-109 Reduced 1.01%	10,718 $5.07 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $516,564 - $656,618	-1,080 Reduced 9.07%	10,827 $5.23 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $4.72 Million - $5.7 Million	8,663 Added 267.05%	11,907 $6.67 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $1.84 Million - $2.4 Million	-3,723 Reduced 53.44%	3,244 $2.02 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $257,850 - $379,227	-767 Reduced 9.92%	6,967 $3.4 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $4.53 Million - $6.22 Million	-16,512 Reduced 68.1%	7,734 $2.9 Million
Q3 2019 Nov 05, 2019	SELL	$273.46 - $318.39 $547,193 - $637,098	-2,001 Reduced 7.62%	24,246 $6.73 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $90.1 Million - $125 Million	-300,814 Reduced 91.97%	26,247 $8.22 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $45.5 Million - $53.8 Million	122,363 Added 59.78%	327,061 $134 Million
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $9.89 Million - $11.9 Million	29,457 Added 16.81%	204,698 $76.5 Million
Q3 2018 Oct 25, 2018	SELL	$351.14 - $408.51 $636,265 - $740,220	-1,812 Reduced 1.02%	175,241 $70.8 Million
Q2 2018 Jul 30, 2018	SELL	$284.6 - $344.99 $38 Million - $46.1 Million	-133,671 Reduced 43.02%	177,053 $61.1 Million
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $10.1 Million - $12.6 Million	-32,041 Reduced 9.35%	310,724 $107 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $57.1 Million - $74.9 Million	-159,333 Reduced 31.73%	342,765 $129 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $37.4 Million - $43.7 Million	86,705 Added 20.87%	502,098 $224 Million
Q2 2017 Aug 14, 2017	BUY	N/A	415,393	415,393 $204 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Regeneron Pharmaceuticals, Inc. Transaction History